ScoreWhy is Gujarat Kidney & Super Speciality Ltd ?
1
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.08 times
2
Healthy long term growth as Net Sales has grown by an annual rate of 0% and Operating profit at 0%
3
With a growth in Net Sales of 2.87%, the company declared Very Positive results in Mar 26
- NET SALES(Q) Highest at Rs 30.58 cr
- PAT(Q) Highest at Rs 5.04 cr.
4
With ROE of 6.1, it has a Very Expensive valuation with a 4.1 Price to Book Value
- Over the past year, while the stock has generated a return of NA, its profits have risen by 65%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Gujarat Kidney should be less than 10%
- Overall Portfolio exposure to Hospital should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Hospital)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
12.54
Debt to EBITDA (avg)
0.92
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.74
Tax Ratio
20.82%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
5.44%
ROCE (avg)
26.45%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
68
Industry P/E
59
Price to Book Value
4.15
EV to EBIT
45.89
EV to EBITDA
37.89
EV to Capital Employed
4.53
EV to Sales
12.45
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
9.87%
ROE (Latest)
6.14%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
Mildly Bullish
KST
Dow Theory
Mildly Bearish
OBV
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend27What is working for the Company
NET SALES(Q)
Highest at Rs 30.58 cr
PAT(Q)
Highest at Rs 5.04 cr.
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Gujarat Kidney
Net Sales - Quarterly
At Rs 30.58 cr has Grown at 99.8% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 15.31 CrMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 5.04 cr has Grown at 71.9% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 2.93 CrMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
Highest at Rs 30.58 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 5.04 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
